1. Introduction
Professional football players are exposed to physical interaction with other persons, and also, due to the nature of their job, are engaged in travel activities. Consequently, this occupational group may be at risk of infectious diseases [
1,
2]. On the other hand, there is evidence from surveillance data that the incidence of injuries is higher than the incidence of illness among professional footballers [
3]. However, it has been pointed out that even mild diseases could have negative impact on the performance of professional footballers and also prevent them from participating in official football matches [
4]. Moreover, even minor infections can reduce the footballer’s ability to sustain heavy training [
4,
5].
The Union of European Football Associations (UEFA) published official regulations and suggested that every professional football player must have a complete vaccination record according to the national vaccination program of the country where the football player works [
6].
There is sparse information on the vaccination practices of high-level professional footballers, and to the best of our knowledge, there is no relevant information on the vaccination practices related to low-category professional footballers.
We conducted a descriptive, cross-sectional study aiming to explore the vaccination practices of the chief medical officers (CMOs) of all low-category (Greek Football League, Second and Third Division) football clubs in Central Greece.
2. Materials and Methods
A questionnaire was developed and included questions on the vaccination practices of football players. Two CMOs were used for pilot testing of the questionnaire. Face-to-face interviews were used for pilot testing and data collection. The participating chief medical officers (CMOs) of the fifteen low-category football teams in Central Greece (Greek Football League, Second and Third Division) were asked to report on their vaccination recommendation practices regarding footballers. In particular, they were asked to report whether they recommended vaccination against diphtheria, tetanus, pertussis, polio, pneumococcal, seasonal influenza, hepatitis B, hepatitis A, measles–mumps–rubella, meningitis A, C, Y, W (options: yes/no). In addition, participants were asked to provide an answer to the “qualitative” aspect of the questionnaire, which comprised the following open-ended question: “In your opinion, what are the most important problems related to the assessment of footballers’ vaccination status?”. The 10 football teams included players from around the world; the total number of players participating in this study was 268. The majority of them were Greek, and the number of players coming from countries other than Greece was 42. Data were tabulated, and descriptive statistics were used for presentation of the results. In particular, the absolute (n) and relative frequencies (%) were presented. Statistical analysis was performed using the Excel software. All participants gave their informed consent for participation in the study, and all responses were anonymized.
3. Results
Overall, 10 out of the 15 CMOs (response rate: 66.5%) participated in the survey. All participating physicians (100%) recommended a vaccine against Tetanus (
Table 1). Influenza, and Hepatitis A and B vaccines were not recommended (
Table 1). This was also the case for Diphtheria, pertussis and measles–mumps–rubella vaccines. In addition, vaccines against meningitis A, C, Y, W strains for adults were also not recommended. The qualitative feedback from the participants revealed the lack of guidelines for vaccination in teams and professional footballers. The lack of vaccination guidelines for footballers and gaps related to access to the vaccination history of footballers were the main problems reported by the participating CMOs.
4. Discussion
In the present study, we reported a unanimous recommendation for the Tetanus vaccine and no recommendation for the other vaccines recommended by the Greek National Immunization Program for adults. These data contradict the findings of a recent Greek survey conducted among the chief medical officers of Super League Greece. In fact, this study reported a prevalence of recommendation for vaccination varying from 12% for Diphtheria, Tetanus, Pertussis and Polio to 87% for seasonal influenza [
7]. In addition, this finding contradicts the results provided by an Italian study from Serie-A, which reported an influenza vaccination rate of 40% [
2].
Hepatitis A and B, Diphtheria, Pertussis, Polio and Measles–Mumps–Rubella are recommended vaccines, according to the Greek National Immunization Program, and both vaccines should be given at preschool age. Perhaps this may be the reason why the medical staff of the teams did not recommend these vaccines. Consequently, we cannot exclude the probability that footballers may have been vaccinated against these infectious agents during childhood. Nevertheless, this important information is not included in our database. In particular for Hepatitis B, as an occupational risk to footballers, it should be noted that previous researchers reported a lack of evidence for transmission among Australian footballers [
8]. On the contrary, Constantini and colleagues recommended vaccination against Hepatitis B because high-level athletes were considered as a population at risk of various infections, given the nature of their work [
9]. Furthermore, it has been suggested that professional athletes should receive all the vaccinations recommended for the general population [
10]. Lastly, Signorelli and coworkers suggested specific immunization practices, including a check for childhood and adolescence immunizations, as well as routine immunizations, including influenza (annually) and decennial booster doses for tetanus and diphtheria [
11].
Our study has several limitations. The study was questionnaire based, and information bias may have occurred. The regional cross-sectional design is not representative of all teams in Football Leagues I and II in Greece. With respect to the non-respondents (response rate = 67%), we acknowledge the possible occurrence of selection bias, since we were unable to obtain the information from non-respondents.
The inability of the study group to confirm the vaccination history of each athlete individually is another limitation of the study. In addition, we investigated the vaccine recommendation practices, and we were unable to verify the actual vaccination coverage among the players or to report on the seroprevalence levels of vaccinations. Lastly, we acknowledge that not addressing the question of why CMOs would not recommend routine vaccinations is an important limitation of the present study. This topic should be addressed in future research.
5. Conclusions
A present study showed poor vaccination practices in low categories of professional football teams in Central Greece. These findings are in marked contrast to a recent survey among the chief medical officers of Super League Greece, which demonstrated better vaccination practices than the present study. Further work is needed in order to update the vaccination practices for footballers of low professional category in Greece. Moreover, the present study revealed the importance of the absence of guidelines on vaccination of football players. Lastly, our findings provide useful insights regarding the immunization practices of football players in low professional categories in Greece and would help policy makers adopt a comprehensive approach to the vaccination of professional footballers.
Author Contributions
Conceptualization, D.P. and G.R.; methodology, D.P., G.M. and G.R.; validation, D.P. and G.R.; formal analysis, D.P., G.M., I.A. and G.R.; investigation, D.P.; resources, D.P. and G.R.; data curation, D.P. and G.R.; writing—original draft preparation, D.P., I.A. and G.R.; writing—review and editing, D.P. and G.R.; supervision, D.P. and G.R. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
The ethics committee of the School of Health Sciences of Technological Education Institute of Thessaly granted approval for the research protocol of the study.
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
Not applicable.
Acknowledgments
The authors of this study would like to thank the medical staff of the ten teams of Football League I and II Greece for their valuable collaboration in completing the research.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Pipe, A.L. International travel and the elite athlete. Clin. J. Sport Med. 2011, 21, 62–66. [Google Scholar] [CrossRef] [PubMed]
- Signorelli, C.; Odone, A.; Miduri, A.; Cella, P.; Pasquarella, C.; Gozzini, A.; Tamburrino, P.; Castellacci, E. Flu vaccination in elite athletes: Survey among Serie A soccer teams. Acta Biomed. 2016, 87, 117–120. [Google Scholar] [PubMed]
- Dvorak, J.; Junge, A.; Derman, W.; Schwellnus, M. Injuries and illnesses of football players during the 2010 FIFA World Cup. Br. J. Sports Med. 2011, 45, 626–630. [Google Scholar] [CrossRef] [PubMed]
- Gleeson, M. Immune function in sport and exercise. J. Appl. Physiol. 2007, 103, 693–699. [Google Scholar] [CrossRef] [PubMed]
- Orhant, E.; Carling, C.; Cox, A. A three-year prospective study of illness in professional soccer players. Res. Sports Med. 2010, 18, 199–204. [Google Scholar] [CrossRef] [PubMed]
- UEFA Medical Regulations 2017 Edition. Available online: http://www.uefa.com/MultimediaFiles/Download/uefaorg/Medical/02/50/25/38/2502538_DOWNLOAD.pdf (accessed on 14 September 2022).
- Papagiannis, D.; Rachiotis, G.; Xanthopoulos, A.; Simou, A.; Zilidis, C.; Triposkiadis, F. Vaccination practices and influenza in professional football players in Greece. Occup. Med. 2020, 70, 200–202. [Google Scholar] [CrossRef] [PubMed]
- Siebert, D.J.; Lindschau, P.B.; Burrell, C.J. Lack of evidence for significant hepatitis transmission in Australian Rules footballers. Med. J. Aust. 1995, 162, 312–313. [Google Scholar] [CrossRef] [PubMed]
- Constantini, N.; Ken-Dror, A.; Eliakim, A.; Galatzkia, L.; Morag, A.; Mann, G.; Volach, B.; Asharov, J.; Shoval, D. Vaccinations in Sports and Recommendations for Immunization Against Flu, Hepatitis A and Hepatitis B. Harefuah 2001, 140, 1191–1195. [Google Scholar] [PubMed]
- Tafuri, S.; Sinesi, D.; Gallone, M.S. Vaccinations among athletes: Evidence and recommendations. Expert Rev. Vaccines 2017, 16, 867–869. [Google Scholar] [CrossRef] [PubMed]
- Signorelli, C.; Gozzini, A. Guidelines for immunization practices in professional athletes. Ig. Sanita Pubbl. 2011, 67, 387–400. [Google Scholar] [PubMed]
Table 1.
Recommendations for vaccination in Football League II.
Table 1.
Recommendations for vaccination in Football League II.
Vaccines–Antigens | Teams n% | Teams n% |
---|
Yes | No |
---|
Diphtheria | | 10/10 | 100% |
Tetanus | 10/10 | 100% | |
Pertussis | | 10/10 | 100% |
Polio | | 10/10 | 100% |
Pneumococcal | | 10/10 | 100% |
Seasonal influenza | | 10/10 | 100% |
Hepatitis B | | 10/10 | 100% |
Hepatitis A | | 10/10 | 100% |
Measles–Mumps–Rubella | | 10/10 | 100% |
Meningitis A, C, Y, W | | 10/10 | 100% |
| Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).